Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Prime Medicine Inc
(NQ:
PRME
)
4.420
+0.280 (+6.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prime Medicine Inc
< Previous
1
2
3
Next >
PRME Stock Earnings: Prime Medicine Misses EPS for Q2 2024
August 08, 2024
PRME stock results show that Prime Medicine missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 08, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Present at Upcoming Investor Conferences
May 30, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 29, 2024
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.
Via
InvestorPlace
Exposures
Product Safety
Recap: Prime Medicine Q4 Earnings
March 01, 2024
Via
Benzinga
Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio
May 25, 2024
Alphabet may have strong insight into both company's industries.
Via
The Motley Fool
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
May 17, 2024
Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential.
Via
InvestorPlace
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
May 17, 2024
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.
Via
InvestorPlace
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 13, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024
May 10, 2024
PRME stock results show that Prime Medicine beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
May 10, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
May 08, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
May 02, 2024
Via
Benzinga
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
May 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
April 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 29, 2024
Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!
Via
InvestorPlace
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
April 29, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 26, 2024
Via
Benzinga
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
April 23, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
2 Magnificent Growth Stocks With Room to Run
March 27, 2024
These deeply undervalued growth stocks could be big winners for patient shareholders.
Via
The Motley Fool
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
March 14, 2024
Explore short-squeeze stocks for potential surges, spotlighting investor strategies and trends that could benefit your portfolio.
Via
InvestorPlace
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
March 01, 2024
On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.
Via
InvestorPlace
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
March 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Participate in Upcoming Investor Conferences
February 28, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
February 20, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Pricing of Upsized Public Offering
February 14, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Proposed Public Offering of Common Stock
February 14, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
January 25, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.